Member Info for Jungmana

Must add over 130m traded since placing announcement.
Too undervalued at 4p imo

Last of the placing overhang being cleared and we could be back over 4p today.
Over 50m volume traded this week

Added some about 3.70p trying to get a 1m holding here.

Yes 8p is possible in that time frame. Why not?

Short term expected news flow:

NXP002 - Covid trial announcement
NXP002 - transformative deal on Asia rights for IPF
NXP004 - full preclinical study results backing up pilot study outperforming current standard of care in fibrosis
Vistagen - update on collaboration and development into phase 3 trials
Ebers - ongoing patent applications and commercialisation of first product with 20% royalties.

That post nicely sums up NFX. A no brainer at GBP 15m market cap today

The next big covid related stock. The products we have could be used in treatment of people suffering from the effects of covid.
There are millions world wide suffering from lung issues due to covid even after recovering from the disease.
As punters take notice imo nfx could multiply from here over coming 2 to 4 months .

I hope he/she meant 25p on a successful percy 1 drill?

Imo 3.2p to 3.6p this coming week before a consolidation about 3p. Saffron 2 news could push us a lot higher.
Any extra funding for percy 1 will most likely be by cln's for about $10m ( which will see less than 10% dilution ) should see 5p to 7p by mid December imo.
Bpc is a far better company today than 6 months back

In March with about 3 weeks to last schedule drill the share price reached 5p and heading towards 10p just before covid 19 brought things to a standstill.
Fast forward to today with merger of cerp and licence in Uruguay I see no reason why bpc will not reach 5p again by percy 1 spud in December.

What i normally do in such situations is sell at least half my holding and hold the remainder for the results.
Percy 1 could be life changing for many. 20 to 40p on a good hit imo.

With news due on 301, 401 ,bc201 for covid, imo val should at least double from here by the time full results of 201 is released this quarter.
If a deal is struck with the Japanese company or any other good deal especially on 201 then we will see a much higher share price.
Hold tight for as a lot could happen from now to xmas

Tony, that's a good comparison with Pharos. 6p is reasonable but add the north sea assets and should be at least 10p.

Bounce off the 25p support yesterday which signals a possible retest of the 35p resistance on early next week. If that dam breaks could see a rapid run towards 50p.
Throw all of that out of the window on good news.

Correct they still hold 82.8m shares.

Thot, Do I follow you or Adam Hargreaves and other knowledgeable posters here?
Infact I will be adding tomorrow early doors

Adam Hargreaves increased to 4% (2.4m shares), that's impressive from such an expert in the field. Someone who was a director at Astra zeneca.
Says a lot about VALs prospects

VAL301

VAL301, the same peptide ingredient as VAL201, is being investigated for the treatment of women with endometriosis in the preclinical stage of development.

The Company announced on 1 May 2020 that a Material Transfer Agreement was signed with an undisclosed Japanese pharmaceutical company, which is carrying out laboratory-based evaluations using their own processes to determine whether to enter a licensing agreement with ValiRx for further development of the project.

BC201

On 2 June 2020, the Company announced that it has entered into a collaboration agreement with Oncolytika Limited and Black Cat Bio Limited to consider the potential for VAL201 to be used in conjunction with other components for treatment of patients suffering a hyperimmune response after Coronavirus SARS-CoV2 infection.

Black Cat Bio is co-ordinating the project overall, with project management of specific elements contributed by ValiRx and Oncolytika. ValiRx will provide samples of VAL201 to enable the testing program. Subject to a successful outcome, ValiRx will receive 40% of any licensing income generated by the project.

A competition among pharmas will happen here . This news on val201 is huge in the industry